|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -50.00% |
|
-50.00% | -87.50% |
| 30/05 | Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 29/05 | Stemtech Corporation Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 2L 2L 2L 2L 3L 1.98Cr 3L 19.73L 8L 95.45L 8L 8L 3.32Cr | P/E Ratio 2024 |
-1.46x | P/E Ratio 2025 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 49.74L 43.16L 39.79L 37.28L 69.65L 48Cr 71.11L 4.75Cr 1.84Cr 23Cr 1.87Cr 1.83Cr 80Cr | EV / Sales 2024 |
2.08x | EV / Sales 2025 | 1.78x |
| Free-Float |
87.98% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -50.00% | ||
| 1 week | -50.00% | ||
| Current month | -50.00% | ||
| 1 month | -50.00% | ||
| 3 months | -66.67% | ||
| 6 months | -93.75% | ||
| Current year | -87.50% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0.03 |
| 3 years | 0 | | 0.1 |
| 5 years | 0 | | 11.5 |
| 10 years | 0 | | 11.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Arnold
CEO | Chief Executive Officer | 75 | 19/08/2021 |
| Director of Finance/CFO | 41 | 15/04/2025 | |
John Meyer
PSD | President | 72 | 19/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Arnold
CHM | Chairman | 75 | 19/08/2021 |
John Meyer
BRD | Director/Board Member | 72 | 19/08/2021 |
Benjamin Kaplan
BRD | Director/Board Member | 54 | 17/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/25/23 | Sell | Director | 10,00,000 | 0.7421% | ||
| 26/24/26 | Other | Chief Executive Officer | 25,000 | 0.0239% | ||
| 19/24/19 | Mindshare Holdings, Inc.
| Sell | Company | 25,000 | 0.0239% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.00% | -50.00% | -99.69% | -99.83% | 2L | |
| +1.63% | -2.74% | +17.91% | -18.09% | 6.22TCr | |
| +2.50% | +4.43% | +64.44% | +216.37% | 5.94TCr | |
| -0.92% | +28.60% | +28.60% | +28.60% | 3.89TCr | |
| +0.48% | +10.01% | -55.32% | -65.09% | 3.64TCr | |
| +2.94% | +1.79% | +50.28% | -35.26% | 2.95TCr | |
| +2.32% | +6.51% | +56.62% | +76.65% | 2.15TCr | |
| +7.94% | -3.78% | +78.88% | -59.73% | 1.97TCr | |
| +4.25% | -0.91% | -6.01% | +111.42% | 1.62TCr | |
| +0.78% | -1.57% | +44.59% | +98.01% | 1.59TCr | |
| Average | -2.83% | -3.69% | +18.03% | +25.31% | 3TCr | |
| Weighted average by Cap. | +2.01% | +1.87% | +29.73% | +44.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 50.54L 43.86L 40.43L 37.88L 70.77L 48Cr 72.25L 4.82Cr 1.87Cr 23Cr 1.9Cr 1.86Cr 81Cr | 28.76L 24.96L 23.01L 21.56L 40.28L 28Cr 41.12L 2.74Cr 1.06Cr 13Cr 1.08Cr 1.06Cr 46Cr |
| Net income | -37.7L -32.71L -30.15L -28.25L -52.79L -36Cr -53.89L -3.6Cr -1.39Cr -17Cr -1.42Cr -1.38Cr -60Cr | -40.47L -35.12L -32.37L -30.33L -56.67L -39Cr -57.85L -3.86Cr -1.5Cr -19Cr -1.52Cr -1.49Cr -65Cr |
| Net Debt | 42.34L 36.74L 33.87L 31.73L 59.29L 41Cr 60.53L 4.04Cr 1.56Cr 20Cr 1.59Cr 1.56Cr 68Cr | 47.67L 41.37L 38.13L 35.73L 66.76L 46Cr 68.15L 4.55Cr 1.76Cr 22Cr 1.79Cr 1.75Cr 77Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | 0.000100 $ | -50.00% | 24,42,186 |
| 10/26/10 | 0.000200 $ | +29.03% | 11,08,001 |
| 09/26/09 | 0.000155 $ | -22.50% | 4,52,313 |
| 08/26/08 | 0.000200 $ | 0.00% | 5,45,084 |
| 05/26/05 | 0.000200 $ | 0.00% | 3,89,944 |
- Stock Market
- Stocks
- STEK Stock
Select your edition
All financial news and data tailored to specific country editions
